LFWD
Lifeward Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$5.93
−1.17%Year over year
Reported trailing growth
- Revenue
- -10.7%
- EBITDA
- -61.5%
- EBIT
- +5.7%
- EPS
- +55.1%
- Free cash flow
- +4.3%
- Operating cash flow
- +4.4%
Forward estimates
Based on analyst estimates
- Revenue
- +77.1%
- EBITDA
- +82.7%
- EPS
- +86.9%
Three-year CAGR
- Revenue
- +58.7%
- EBITDA
- +22.4%
- EBIT
- +13.6%
- Net income
- +31.2%
- EPS
- +57.1%
- Free cash flow
- +22.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026